The clinical
decision support system market size is expected to cross $1.5 billion by
2022, growing at a CAGR of 21.5% between 2016-2022. The CDSS market is driven
by five major factors, including growing
demand for advanced healthcare information systems, growing investments by HIT
players, growing need for remote patient monitoring services, and increasing
support from government organizations.
The massive unexplored CDSS across the globe has created
abundant opportunities for the major players to exploit the potential of the
CDSS market. Although, there has been significant development in the developed
economies of European Union (EU) and the U.S., the clinical decision support
system market is still at its nascent form, especially in the developing
countries of Asia, Latin America, and Africa. A high growth in numbers of end
user including hospitals, and pharmacy has been witnessed in the developing
countries of these regions, which provides immense growth opportunities for the
CDSS market.
The Asia-Pacific
market for CDSS is expected to grow at a CAGR of 23.2% between 2016-2022. The clinical
decision support system market in
Asia-Pacific is growing, due to growing geriatric population and upsurge in the occurrence rate of different chronic diseases. In
addition, the improving healthcare infrastructure, and favorable government
support, such as investments and grants has fueled the demand of HIT systems
including CDSS in the region. China is expected to grow at a CAGR of 27% during
the forecast period and reach $114.3 million by 2022, in the Asia-Pacific CDSS
market.
Explore
Report at@ https://www.psmarketresearch.com/market-analysis/clinical-decision-support-system-market
Some of the key companies operating in the CDSS market
include Cerner Corporation, RELX Group PLC, Epic Systems Corporation, General
Electric Company, McKesson Corporation, Zynx Health Incorporated, International
Business Machine Corporation, Siemens AG, Allscripts Healthcare Solutions
Inc., Meditech and Wolters Kluwer.
GLOBAL CDSS MARKET SEGMENTATION
By Product
- Integrated
CDSS Solutions
- Standalone
CDSS Solutions
By Application
- Drug
Dosing Support
- Clinical
Guidelines
- Clinical
Reminders
- Drug-Drug
Interactions
- Drug
Allergy Alerts
- Others
By Model
- Knowledge-based
CDSS Solutions
- Non-Knowledge-Based
CDSS Solutions
By Mode of Delivery
- On-Premises
- Web-Based
- Cloud-Based
By Component
- Software
- Hardware
- Services
By Healthcare Provider Entity Capacity
- Less
than 100 Beds
- 100–199
Beds
- 200–299
Beds
- 300–399
Beds
- 400–499
Beds
- More
than 500 Beds
By Region
- North
America
- U.S.
- Canada
- Rest
of North America
- Western
Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Rest
of Western Europe
- Central
& Eastern Europe
- Russia
- Rest
of Central & Eastern Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest
of Asia-Pacific
- Latin
America
- Brazil
- Rest
of Latin America
- Middle East and Africa
Source: P&S Intelligence
